hero image
Webinar

Monitoring patients: Value of sensitive and standardized testing

On-demand
icon_0085_cc_gen_calendar-s
May 19, 2024
icon_0310_cc_gen_timeinterval-s
60 minutes

About this webinar

In her insightful talk, Prof. Branford discusses how standardization of molecular testing was achieved for patients with chronic myeloid leukemia and how this model could be applied for other blood cancers. Real-time quantitative PCR has been a gold standard for quantitative assessment of disease levels but digital PCR could provide additional benefits for the precise assessment of measurable residual disease.

Speakers

Fill out the form to take part in the event